Sep 29

QP 28 - Actionable Biomarkers: Guiding Therapy Selection and De-escalation

1167 - Phase 2 Trial of Metastasis Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer

05:40pm - 05:45pm ET

Presenter(s)

Rachel Glicksman, MD - University of Toronto, Toronto, ON